Nuclear Poly(ADP-Ribose) Activity Is a Therapeutic Target in Amyotrophic Lateral Sclerosis

Acta neuropathologica communications - United Kingdom
doi 10.1186/s40478-018-0586-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Poly(ADP-Ribose) Polymerase-1: A Novel Therapeutic Target in Necrotizing Enterocolitis

Pediatric Research
Child HealthPediatricsPerinatology
2011English

Asthma and Poly(ADP-Ribose) Polymerase Inhibition: A New Therapeutic Approach

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Amyotrophic Lateral Sclerosis

2012English

Amyotrophic Lateral Sclerosis

2020English

Amyotrophic Lateral Sclerosis

Current Opinion in Neurology
Neurology
2016English

Family-Wide Analysis of Poly(ADP-Ribose) Polymerase Activity

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2014English

Targeting Poly(ADP-Ribose) Polymerase Activity for Cancer Therapy

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2010English

Mitochondrial Superoxide Dismutase Activity in Amyotrophic Lateral Sclerosis

The Open Spine Journal
2009English

Amyotrophic Lateral Sclerosis

Advances in Experimental Medicine and Biology
BiochemistryMedicineGeneticsMolecular Biology
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy